Results 151 to 160 of about 27,191 (241)

Extensive myelofibrosis responsive to treatment for acute erythroblastic leukaemia

, 2006
Intense myelofibrosis is rarely associated with de novo acute myeloid leukaemia (AML) except in acute megakaryoblastic leukaemia (AML-M7) where there is diffuse marrow fibrosis as a consequence of proliferation of neoplastic myeloid cells.AML ...
ZAINAB BINTI AWANG NGAH
core  

Association Between Transfusion Status, Hemoglobin Levels, and Patient-Reported Outcomes in Myelofibrosis: A Post Hoc Clinical Trial Analysis. [PDF]

Cancer Med
Mesa R, Palmer JM, Palandri F, Masarova L, Harrison CN, Mazerolle F, M'hari M, Liu T, Zhang S, Cardellino A, Wang Z, Ellis CE, Patnaik D, Regnault A, LeBlanc TW.   +14 more
europepmc   +1 more source

Myelofibrosis

, 2012
Renu Saxena, HP Pati, M Mahapatra
  +4 more sources

Acquired Hemophilia A Associated with Post-Essential Thrombocythemia Myelofibrosis: A Rare Autoimmune Bleeding Complication [PDF]

Turk J Haematol
Kır S, Patır DÇ, Demirci Z, Şahin F.
europepmc   +1 more source

Acute promyelocytic leukemia with secondary myelofibrosis and positive CD34 expression. [PDF]

Int J Clin Exp Pathol
Demianets R, Tran T, Zhang Y, Gamayo A, Zhao X, Rezk SA.   +5 more
europepmc   +1 more source

VEGFA rs3025039 is associated with phenotype severity of myelofibrosis‐type megakaryocyte dysplasia

eJHaem, 2023
Giovanni Barosi, Paolo Catarsi, Rita Campanelli, Margherita Massa, Adriana Carolei, Carlotta Abbà, Annalisa deSilvestri, Robert Peter Gale, Vittorio Rosti   +8 more
doaj   +1 more source

Hydroxyurea-Associated Wunderlich Syndrome in Triple-Negative Myelofibrosis: A Case Report and Literature Review. [PDF]

Case Rep Hematol
Erol V, Güzel Z, Akgün İE, Ecer G.
europepmc   +1 more source

Sequential Analysis of Murine Myelofibrosis Models Using a Novel Deep Learning-Based Fibrosis Quantitative Method. [PDF]

EJHaem
Kawamura T, Maekawa T, Kouzu K, Ogata H, Tachi N, Kato S, Osawa Y, Einama T, Sato K, Kobayashi S.   +9 more
europepmc   +1 more source

Correction: Pacritinib in transplant-eligible myelofibrosis: final analysis of the phase II HOVON-134 trial. [PDF]

Bone Marrow Transplant
Van Dijck R, van der Holt B, Broers AEC, Hazenberg MD, Devos T, van der Poel MWM, Breems D, Deleu L, Schuthof BAG, van Hooije CMC, Cornelissen JJ, Schaap NPM, Te Boekhorst PAW.   +12 more
europepmc   +1 more source

Real-world prevalence and outcome of elevated right ventricular systolic pressure in myelofibrosis. [PDF]

Cardiooncology
Sharma AB, Wang E, Selvakumar S, Koelmeyer H, Shetty S, Buckley K, Mo Q, Smith T, Chao A, Balen C, Mannam G, Yudiono J, Lien K, Khatib S, Paduchuri V, Al Ali N, Song J, Nishihori T, Lancet JE, Alomar M, Cleveland JL, Kuykendall A, Komrokji RS, Yun S, Lee DH.   +24 more
europepmc   +1 more source